单价疫苗（EB病毒）市场按应用和地区划分

Monovaccine (Epstein - Barr virus) Market, By Application, By Geography

出版日期: 2026年01月22日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，单价疫苗（EB病毒）市值为 83.4 亿美元，预计到 2033 年将达到 120.5 亿美元，2026 年至 2033 年的复合年增长率为 5.40%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	83.4亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	5.40%	2033 年的预测值：	120.5亿美元

EB病毒（EBV）感染人类B细胞，并在网状内皮系统（RES）内扩散。已知此病毒可引起多种自体免疫疾病，包括多发性硬化症、乳糜泻、全身性红斑性狼疮、幼年特发性关节炎、发炎性肠道疾病、类风湿性关节炎和第一型糖尿病。多项研究已将EB病毒与某些淋巴系统癌症和EB病毒联繫起来。例如，辛辛那提儿童医院医学中心2018年的报告发现，EBV感染会增加多发性硬化症的风险。当人体遇到病毒和细菌等外来物质时，会利用B细胞产生抗体来对抗这些病原体。然而，在EB病毒感染中，病毒会入侵并控制B细胞。 EBV透过产生异常转录因子来调控基因表现，从而实现这一目标。

研究人员已证实，病毒转录因子EBNA2能够结合人类基因组中与上述疾病相关的多个位点。 EB病毒也与多种人类癌症有关，包括伯基特淋巴瘤、鼻咽癌和移植后淋巴增生性疾病。然而，EB病毒导致不同类型癌症的确切原因目前仍在研究中。例如，在2017年发表于《妇科肿瘤学杂誌》的一项研究中，卡利卡里联邦大学的研究人员报告称，EB病毒阳性女性子宫颈癌的发生率是未感染EB病毒女性的四倍，这表明EB病毒感染会增加子宫颈癌的风险。

市场动态

许多大学都在积极进行研发活动，致力于开发新型单价疫苗。
例如，自2017年以来，堪萨斯大学工程学院和药学院一直在研究人类免疫反应的遗传学，以研发一种有效的EB病毒（EBV）疫苗。各机构加强对EBV新型疫苗的研究力度，预计将推动全球EB病毒疫苗市场的成长。
此外，与 EB 病毒相关的各种疾病的高发生率预计未来将增加对该病毒疫苗的需求。
例如，根据英国癌症研究中心2014年发表的数据，全球约有62,400例何杰金氏淋巴瘤病例，其中约28,600例与EB病毒相关。同一资讯来源估计，英国每年约有45%的何杰金氏淋巴瘤是由EB病毒引起的。
根据英国癌症研究中心2014年发布的数据，EB病毒是一种非常常见的病毒，会增加鼻咽癌的风险。据同一资讯来源称，全球约有80,000例确诊的鼻咽癌病例，其中约有78,100例与EB病毒有关。

本次调查的主要特点

本报告对全球单价疫苗（EB病毒）市场进行了详细分析，并给出了市场规模（十亿美元）。
它还重点介绍了各个细分市场的潜在商机，并解释了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、区域前景以及主要企业采取的竞争策略的重要见解。
该研究根据以下参数对全球单疫苗（EB病毒）市场的主要企业进行了分析：公司概况、财务表现、产品系列、地理扩张、分销策略、关键发展和策略以及未来计划。
参与单一疫苗（EB病毒）研发的大学和机构包括英国癌症研究中心、美国国立卫生研究院 (NIH)、香港中文大学、Genocea Biosciences 公司、Dana-Farber 癌症研究所、德国癌症研究所和明尼苏达大学。
本报告的研究结果将帮助负责人和经营团队就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
这份全球单株疫苗（EB病毒）市场报告的目标受众包括该行业的各类相关人员，例如投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种策略矩阵轻鬆做出决策，这些矩阵用于分析全球单株疫苗（EB病毒）市场。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 8.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.40%	2033 Value Projection:	USD 12.05 Bn

Epstein-Barr virus (EBV) infects human B cells and spreads the infection throughout the entire reticuloendothelial system (RES). The virus is known to cause various autoimmune disorders including multiple sclerosis, celiac disease, systemic lupus erythematosus, juvenile idiopathic arthritis, inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes. Various research studies have linked Epstein-Barr virus to certain cancers of the lymphatic system and lupus. For instance, according to the report from the Cincinnati Children's Hospital Medical Center, in 2018, infection with the Epstein-Barr virus (EBV) increases the risk of developing multiple sclerosis. When the human body encounters foreign bodies such as virus or bacteria, it uses B-cells to produce antibodies to fight against these agents. However, in Epstein-Barr infections, the virus invades and takes control of B-cells. EBV invades B cells by producing abnormal transcription factors that regulate gene expression.

The researchers revealed that virus-derived EBNA2 transcription factor binds to several spots in the human genome that are linked to above mentioned diseases. Moreover, EBV is linked with several human cancers such as Burkitt's lymphoma, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disorder. However, the exact reason for EBV leading to different types of cancers is currently being studied by various researchers. For instance, according to the study published in Gynecologic Oncology Journal, 2017, researchers from the Federal University of Cariri stated that cervical carcinoma was four times more prevalent among EBV positive women than in women without EBV infection. This indicated that EBV infection increases the risk of cervical carcinoma.

Market Dynamics

Various universities are involved in frequent research and development activities for development of novel monovaccines.
For instance, since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Epstein - Barr virus or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV is expected to drive the global monovaccines (Epstein - Barr virus) market growth.
Furthermore, high prevalence of various diseases related to EBV virus is expected to rise demand for its vaccine in future.
For instance, according to data published by Cancer Research U.K. in 2014, around 62,400 cases of Hodgkin's lymphoma were recorded worldwide, out of which around 28,600 cases were associated with Epstein-Barr virus. According to the same source, it was estimated that EBV is responsible for an estimated 45% of Hodgkin's lymphoma in the U.K., annually.
According to data published by Cancer Research U.K. in 2014, EBV is a very common virus that can increase the risk of nasopharyngeal cancer. According to same source, there were around 80,000 cases of nasopharyngeal carcinoma worldwide, out of which around 78,100 cases were associated with Epstein-Barr virus.

Key features of the study

This report provides in-depth analysis of global monovaccine (Epstein-Barr Virus) market and provides market potential (US$ Billion)
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global monovaccine (Epstein-Barr Virus) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Universities and organizations involved in development of monovaccine (Epstein-Barr virus) includes Cancer Research U.K., National Institutes of Health, Chinese University of Hong Kong, Genocea Biosciences, Inc., Dana-Farber Cancer Institute, German Cancer Research Institute, and University of Minnesota
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global monovaccine (Epstein-Barr Virus) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global monovaccine (Epstein-Barr Virus) market

Market Segmentation

By Application
- Mononucleosis
- Endemic Burkitt's Lymphoma
- Hodgkin's Lymphoma
- Gastric Carcinomas
- Multiple sclerosis
- Nasopharyngeal Carcinoma
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Cancer Research UK
- National Institutes of Health
- Chinese University of Hong Kong
- Genocea Biosciences, Inc.
- Dana-Farber Cancer Institute
- German Cancer Research Institute
- University of Minnesota

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis

4. Global Monovaccine (Epstein-Barr Virus) Market, By Application, 2026 -2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, 2026 - 2033
- Segment Trends
Mononucleosis
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Endemic Burkitt's Lymphoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Hodgkin's Lymphoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Gastric Carcinomas
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Multiple sclerosis
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Nasopharyngeal Carcinoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)

5. Global Monovaccine (Epstein-Barr Virus) Market, By Region

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, For Region, 2026 - 2033
North America
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - U.S.
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Canada
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Latin America
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - Brazil
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Argentina
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Mexico
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Latin America
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Europe
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - U.K.
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Germany
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Italy
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Spain
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
France
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Russia
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Europe
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Asia Pacific
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - China
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
India
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Japan
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
ASEAN
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
South Korea
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Australia
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Asia Pacific
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Middle East
- Market Share Analysis, By Country/Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
  - GCC
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Israel
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Middle East
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Africa
- Market Share Analysis, By Country/Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
  - Northern Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Central Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
South Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)

6. Competitive Landscape

Heat Map Analysis
Company Profiles
- Cancer Research UK
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- National Institutes of Health
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Chinese University of Hong Kong
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Genocea Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Dana-Farber Cancer Institute
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- German Cancer Research Institute
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- University of Minnesota
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies

7. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

单价疫苗（EB病毒）市场按应用和地区划分

Monovaccine (Epstein - Barr virus) Market, By Application, By Geography

市场动态